biopharmaceutical

• 

  Polishing Forex Hedging

  By Richard Gamble  |  October 3, 2012

  As FX volatility grows, companies look for hedging solutions that provide a mix of automation, outsourcing and personal attention.

• Polishing Forex Hedging

  By Richard Gamble  |  September 24, 2012

  As volatility grows, companies look for hedging solutions that provide automation, outsourcing and personal attention.

• 

  From Tech to Biotech

  By John Hintze  |  June 1, 2012

  Gilead CFO Robin Washington has overseen an ERP implementation and the company's $111 billion acquisition of Pharmasset.

• Financial Executives: Keeping Track

  By Hilary Johnson  |  February 15, 2011

  John Luttrell; David Russell; Ted Knopf; Mark Droege; Claus Friis; Jeffrey Buchanan; Herb Cross; David Miller

• Financial Executives: Keeping Track

  By Staff Writer  |  October 1, 2010

  Max Valdes; Jan Berger; John Doherty; Ron Lataille; Jacqualyn Fouse; Thad Johnson; Michael Lawton

• Ready and Able to Fuel Growth

  By Staff Writer  |  October 1, 2010

  Treasury & Risk's 2010 picks of corporate America's outstanding finance executives under the age of 40

• Financial Executives: Keeping Track

  By Staff Writer  |  June 1, 2010

  Charles Noski; Edward Rapp; Charles Bancroft; Irene Esteves; Dilek Samil; Jeff Knobel

• The Financial Virtue of Wellness

  By Russ Banham  |  May 1, 2010

  Corporate fitness and health programs seem to be paying off in bottom-line value as well as in improved productivity.